NDC11 70511016202
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70511-0162-02 | 70511-0162 |
| 70511-0162-2 | 70511-0162 |
| 70511-162-02 | 70511-162 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bortezomib | BORTEZOMIB | MAIA Pharmaceuticals, Inc. | c40e6a28-d577-43d4-bca6-bef28da1d580 | 2021-09-22 | Warnings, Adverse reactions | 70511-162-02 70511-162 70511016202 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.